These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
138 related items for PubMed ID: 8314538
1. Pretreatment plasma levels of fibrinopeptide-A (FPA), D-dimer (DD), and von Willebrand factor (vWF) in patients with operable cervical cancer: influence of surgical-pathological stage, tumor size, histologic type, and lymph node status. Gadducci A, Baicchi U, Marrai R, Facchini V, del Bravo B, Fosella PV, Fioretti P. Gynecol Oncol; 1993 Jun; 49(3):354-8. PubMed ID: 8314538 [Abstract] [Full Text] [Related]
2. Pretreatment plasma levels of fibrinopeptide-A (FPA), D-dimer (DD), and von Willebrand factor (vWF) in patients with ovarian carcinoma. Gadducci A, Baicchi U, Marrai R, Del Bravo B, Fosella PV, Facchini V. Gynecol Oncol; 1994 Jun; 53(3):352-6. PubMed ID: 8206409 [Abstract] [Full Text] [Related]
3. High-risk group in node-positive patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation. Aoki Y, Sasaki M, Watanabe M, Sato T, Tsuneki I, Aida H, Tanaka K. Gynecol Oncol; 2000 May; 77(2):305-9. PubMed ID: 10785483 [Abstract] [Full Text] [Related]
5. [Analysis of the relationship between clinicopathological features and pelvic lymph node metastasis in patients with early stage squamous cell carcinoma of the uterine cervix]. Tian QF, Wang XY, Lü WG, Ye F, Xie X. Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):760-3. PubMed ID: 19087544 [Abstract] [Full Text] [Related]
7. A comparison of prognoses of pathologic stage Ib adenocarcinoma and squamous cell carcinoma of the uterine cervix. Nakanishi T, Ishikawa H, Suzuki Y, Inoue T, Nakamura S, Kuzuya K. Gynecol Oncol; 2000 Nov; 79(2):289-93. PubMed ID: 11063659 [Abstract] [Full Text] [Related]
8. Surgical pathologic factors that predict recurrence in stage IB and IIA cervical carcinoma patients with negative pelvic lymph nodes. Samlal RA, van der Velden J, Ten Kate FJ, Schilthuis MS, Hart AA, Lammes FB. Cancer; 1997 Oct 01; 80(7):1234-40. PubMed ID: 9317173 [Abstract] [Full Text] [Related]
9. [Prognostic factors of stage IB and IIA carcinoma of the cervix treated by surgery]. Zhang WH, Wu LY, Bai P, Li SM, Zhang R, Li B, Sun JH, Wu AR. Zhonghua Zhong Liu Za Zhi; 2004 Aug 01; 26(8):490-2. PubMed ID: 15555341 [Abstract] [Full Text] [Related]
10. Plasma D-dimer levels show correlation with number of lymph node metastases in patients with esophageal cancer. Tomimaru Y, Yano M, Takachi K, Kishi K, Miyashiro I, Ohue M, Ohigashi H, Sasaki Y, Ishikawa O, Imaoka S. J Am Coll Surg; 2006 Jan 01; 202(1):139-45. PubMed ID: 16377507 [Abstract] [Full Text] [Related]
11. Early cervical carcinoma: the natural history of lymph node involvement redefined on the basis of thorough parametrectomy and giant section study. Benedetti-Panici P, Maneschi F, D'Andrea G, Cutillo G, Rabitti C, Congiu M, Coronetta F, Capelli A. Cancer; 2000 May 15; 88(10):2267-74. PubMed ID: 10820348 [Abstract] [Full Text] [Related]
13. The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy. Tsai CS, Lai CH, Wang CC, Chang JT, Chang TC, Tseng CJ, Hong JH. Gynecol Oncol; 1999 Dec 15; 75(3):328-33. PubMed ID: 10600284 [Abstract] [Full Text] [Related]
14. Histopathological factors influencing pelvic lymph node metastases in two or more sites in patients with cervical carcinoma undergoing radical hysterectomy. Kamura T, Shigematsu T, Kaku T, Shimamoto T, Saito T, Sakai K, Mitsumoto M, Nakano H. Acta Obstet Gynecol Scand; 1999 May 15; 78(5):452-7. PubMed ID: 10326894 [Abstract] [Full Text] [Related]
15. [Radical hysterectomy with pelvic lymphadenectomy in patients with carcinoma of the uterine cervix--3 years' experience]. Bosković V, Glisić A, Petković S. Srp Arh Celok Lek; 1998 May 15; 126(5-6):183-7. PubMed ID: 9863378 [Abstract] [Full Text] [Related]
16. Changes in the demographics and perioperative care of stage IA(2)/IB(1) cervical cancer over the past 16 years. Covens A, Rosen B, Murphy J, Laframboise S, DePetrillo AD, Lickrish G, Colgan T, Chapman W, Shaw P. Gynecol Oncol; 2001 May 15; 81(2):133-7. PubMed ID: 11330939 [Abstract] [Full Text] [Related]